• FPR2/ALX Stimulation Restricts Autoimmune Astrocytopathy via

  2026-07-06

  This study demonstrates that activating FPR2/ALX with Quin-C1 attenuates neuroinflammation and demyelination in a mouse model of autoimmune astrocytopathy, primarily by modulating microglia and NK cell activity. The findings highlight FPR2/ALX as a promising therapeutic target for disorders such as neuromyelitis optica spectrum disorder (NMOSD), where conventional therapies are often insufficient.

• Lipid Scrambling Modulation Amplifies Ferroptosis and Immune

  2026-07-06

  Yang et al. provide evidence that TMEM16F-mediated lipid scrambling at the plasma membrane suppresses ferroptosis, revealing a mechanism by which tumors evade cell death and immune rejection. Disruption of this process potentiates ferroptosis and synergizes with PD-1 blockade, highlighting new therapeutic angles for cancer treatment.

• 3-Deazaadenosine: Precision Epigenetic Inhibition and Antivi

  2026-07-05

  Explore how 3-Deazaadenosine, a potent S-adenosylhomocysteine hydrolase inhibitor, enables advanced methylation pathway studies and preclinical antiviral research. This article uncovers unique mechanistic insights and protocol strategies for researchers seeking reproducible, high-impact results.

• Prunin Suppresses Senecavirus A by Disrupting IRES-Driven Tr

  2026-07-04

  This study reveals that prunin, a natural compound, inhibits Senecavirus A (SVA) replication by targeting the viral internal ribosome entry site (IRES) and disrupting its interaction with key host RNA-binding proteins. The findings not only illuminate a novel antiviral mechanism against SVA but also provide a strategic foundation for future therapeutic development.

• Ether Lipid Biosynthesis in B Cells Enhances Antibody Respon

  2026-07-03

  This study demonstrates that B cell-intrinsic ether lipid biosynthesis, via the peroxisomal enzyme PexRAP (encoded by Dhrs7b), is crucial for robust germinal center formation and effective antibody affinity maturation. The findings clarify metabolic control points in humoral immunity and suggest new avenues for immunological and translational research.

• Doxorubicin in Translational Oncology: Mechanisms and Strate

  2026-07-03

  This thought-leadership article unpacks the mechanistic underpinnings and strategic application of Doxorubicin (Adriamycin) for translational cancer researchers. Integrating the latest evidence on ABC transporter-mediated resistance and new sensitization strategies, we outline how APExBIO’s Doxorubicin empowers discovery, validation, and workflow innovation across solid tumors and hematologic malignancies.

• ABT-737: Shaping Translational Strategies in Apoptosis Resea

  2026-07-02

  This thought-leadership article explores how ABT-737, a potent BCL-2 protein inhibitor, is redefining translational research by bridging mechanistic insights in apoptosis with actionable guidance for oncology and autoimmune diabetes models. Integrating recent breakthroughs, including senolytic applications and advanced protocol optimization, the piece delivers strategic perspectives for researchers aiming to maximize the impact of apoptosis induction studies.

• Breast Cancer Dependence on MCL-1: Canonical Anti-Apoptotic

  2026-07-02

  This study clarifies that breast cancer cell survival is primarily dependent on the canonical anti-apoptotic function of MCL-1, rather than its non-apoptotic roles. These findings underline the therapeutic potential of MCL-1 inhibitors and inform the design of targeted apoptosis induction assays in cancer research.

• MK-2206 Dihydrochloride: Advanced Workflows in Akt Pathway R

  2026-07-01

  MK-2206 dihydrochloride empowers researchers to dissect PI3K/Akt/mTOR signaling with nanomolar precision, streamlining apoptosis and metabolic studies in cancer and bone biology. This guide delivers actionable workflow optimizations, troubleshooting strategies, and cross-domain insights tied to the latest discoveries in Wnt-driven osteogenesis.

• Hydrocortisone (B1951): Practical Guidance for Lab Research

  2026-07-01

  Hydrocortisone (B1951) is designed for researchers studying glucocorticoid receptor signaling, inflammation models, and stress response mechanisms. This product is best suited for in vitro and preclinical workflows where precise control of anti-inflammatory and metabolic modulation is required. It is not recommended for applications needing aqueous or ethanol solubility, or for long-term solution storage.

• Hydrocortisone in Neural Stress Signaling: Beyond Inflammati

  2026-06-30

  Explore hydrocortisone, a key glucocorticoid hormone, as a rapid modulator of neural calcium signaling and stress response. This article offers a unique, neuroscience-focused perspective, contrasting with traditional inflammation model research.

• Elobixibat Hydrate: Applied Workflows with an IBAT Inhibitor

  2026-06-30

  Elobixibat hydrate, a potent ileal bile acid transporter inhibitor, empowers translational and preclinical research in gastrointestinal and metabolic disorders by modulating bile acid signaling with exceptional specificity. This guide details experimental protocols, advanced troubleshooting, and unique assay advantages, helping researchers translate mechanistic insight into reproducible results.

• Hydrocortisone in Research: Protocols, Performance, and Pitf

  2026-06-29

  Hydrocortisone is a gold-standard glucocorticoid hormone for dissecting inflammation, barrier function, and neuroprotection in preclinical models. This article demystifies its experimental use, from optimized solubilization to troubleshooting protocol bottlenecks, with direct translation of recent breakthroughs in tumor immune response research.

• Green Spectrophotometric Quantification of Alfuzosin HCl Mix

  2026-06-29

  Alqahtani et al. (2024) present the first spectrophotometric methods for quantifying Alfuzosin HCl and tadalafil in fixed-dose combination tablets, overcoming spectral overlap to enable robust, affordable analysis. This methodological advance supports precision research in benign prostatic hyperplasia pharmacotherapy and routine pharmaceutical quality control.

• Indomethacin Sodium Trihydrate: Reliable Workflows in Cell A

  2026-06-28

  This article provides scenario-driven guidance for biomedical researchers and lab technicians employing Indomethacin Sodium Trihydrate (SKU C6491) in cell viability, proliferation, and cytotoxicity assays. Grounded in evidence and real workflow challenges, it details how this compound’s validated protocols, high solubility, and dual COX/Wnt pathway modulation empower reproducible, efficient anti-inflammatory research.

11866 records 1/792 page Next 12345 下5页 Last page